以合理用药为核心的中药临床药师参与新型冠状病毒肺炎（NCP）防治的基本切入点及必要性分析＊

新型冠状病毒肺炎爆发以来，我国以最快的响应速度发布了《新型冠状病毒感染的肺炎诊疗方案》，并明确指示在新型冠状病毒肺炎防治工作中建立健全中西医协作机制，使中医药尽早、尽快参与其中，积极发挥其作用。本研究从中药临床药学的角度，以国家及各省区发布的新型冠状病毒肺炎的预防及诊疗方案为切入点，分析中药临床药师参与新型冠状病毒肺炎防治的可行性及必要性，提出中药临床药师参与新型冠状病毒肺炎的防治及公共卫生突发事件的观点，以期能为壮大中医药参与传染性疾病队伍，完善中医药多力量参与公共卫生突发事的体制提供参考。

At the Core of Rational Drug Use of Analysis on Entry Points and the Necessity of Traditional Chinese Clinical Pharmacists Participating in the Treatment of NCP

Since the outbreak of novel coronavirus pneumonia (NCP) in Wuhan, the country has issued the "Pneumonitis Diagnosis and Treatment Program for novel coronavirus pneumonia" with the fastest response speed, and clearly instructs the establishment of a sound Chinese and Western medicine collaboration mechanism in the prevention and treatment of novel coronavirus pneumonia, so that Chinese medicine can be established as soon as possible. Get involved as soon as possible and actively play the role of Chinese medicine. From the perspective of clinical medicine of traditional Chinese medicine, this study takes the prevention and diagnosis of novel coronavirus pneumonia released by the country and provinces as the starting point, analyzes the feasibility and necessity of Traditional Chinese medicine clinical pharmacists to participate in the prevention and treatment of novel coronavirus pneumonia, and proposes the clinical practice of traditional Chinese medicine. The point of view of pharmacists participating in the prevention and treatment of novel coronavirus pneumonia and public health emergencies, with a view to providing reference for strengthening the Chinese medicine participation in infectious disease teams and improving the system of multiple forces of Chinese medicine participating in public health emergencies.